Clearstead Advisors LLC Has $2.75 Million Stake in CVS Health Corporation $CVS

Clearstead Advisors LLC lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 103.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,480 shares of the pharmacy operator’s stock after buying an additional 18,538 shares during the period. Clearstead Advisors LLC’s holdings in CVS Health were worth $2,750,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Payden & Rygel acquired a new stake in shares of CVS Health in the third quarter valued at approximately $19,714,000. Avalon Trust Co bought a new position in CVS Health in the third quarter valued at $209,000. Kovitz Investment Group Partners LLC increased its stake in CVS Health by 27.4% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 262,363 shares of the pharmacy operator’s stock valued at $19,780,000 after buying an additional 56,476 shares during the last quarter. Alteri Wealth LLC lifted its position in CVS Health by 3.2% during the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock worth $316,000 after buying an additional 131 shares in the last quarter. Finally, Vestmark Advisory Solutions Inc. boosted its stake in shares of CVS Health by 154.1% during the 3rd quarter. Vestmark Advisory Solutions Inc. now owns 16,185 shares of the pharmacy operator’s stock worth $1,220,000 after buying an additional 9,815 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CVS. Jefferies Financial Group upped their target price on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. UBS Group reissued an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Argus lowered their target price on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Price Performance

Shares of CVS opened at $74.17 on Wednesday. The company’s 50-day moving average is $78.38 and its 200-day moving average is $77.02. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The firm has a market capitalization of $94.36 billion, a PE ratio of 53.75, a PEG ratio of 0.80 and a beta of 0.50. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.6%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.